Skip to main content

Table 1 Participant’s sociodemographic and clinical characteristics pre-program by model and sex

From: Women’s outcomes following mixed-sex, women-only, and home-based cardiac rehabilitation participation and comparison by sex

 

Men*

Women†

Mixed-sex

N = 454

Mixed-sex

N = 543 (74.7%)

Women-only

N = 160 (22.0%)

Home-based

N = 24 (3.3%)

Total

N = 727

Sociodemographic

Age

66.8 ± 11.8

66.7 ± 12.1

68.1 ± 12.1

61.3 ± 16.9

66.9 ± 12.3

Marital status (% married/common-law)

290 (82.2%)***

257 (67.8%)

67 (63.2%)

9 (60.0%)

333 (66.6%)

Highest educational attainment (% ≥ high school)

226 (93.8%)

299 (92.3%)

79 (94.0%)

12 (100.0%)

390 (92.9%)

Language spoken (% English)

313 (95.1%)

411 (96.3%)

111 (98.2%)

20 (100.0%)

542 (96.8%)

Occupational status

 Retired/no formal employment

147 (54.9%)

220 (64.1%)‡‡

74 (80.4%)‡‡

6 (54.5%)

300 (67.3%)†

 Full-time/part-time/ modified/restricted duties

101 (37.7%)

103 (30.0%)‡

16 (17.4%)‡

4 (36.4%)

123 (27.6%)†

 Other (e.g., disability)

20 (7.5%)

20 (5.8%)

2 (2.2%)

1 (9.1%)

23 (5.2%)

Travel time to CR centre (% 0–30 min)

124 (63.3%)

143 (61.1%)

34 (58.6%)

2 (40.0%)

179 (60.3%)

Living situation

 With spouse/partner

212 (70.2%)***

201 (50.9%)

44 (43.6%)

11 (68.8%)

256 (50.0%)

 Alone

41 (13.6%)***

123 (31.1%)

37 (36.6%)

4 (25.0%)

164 (32.0%)

 With family/friends/others

49 (16.2%)

71 (18.0%)

20 (19.8%)

1 (6.3%)

92 (18.0%)

Clinical characteristics

Referral event/procedure§

 PCI

228 (50.6%)***

185 (34.4%)

54 (34.0%)

7 (31.8%)

246 (34.2%)

 Valvular heart disease

34 (7.5%)*

62 (11.5%)

20 (12.6%)

1 (4.5%)

83 (11.5%)

CABG

41 (9.1%)

50 (9.3%)

21 (13.2%)

1 (4.5%)

72 (10.0%)

 Stroke/TIA

40 (8.9%)

52 (9.7%)

13 (8.2%)

2 (9.1%)

67 (9.3%)

 Primary prevention

8 (1.8%)***

41 (7.6%)

10 (6.3%)

1 (4.5%)

52 (7.2%)

 Arrhythmia/Rhythm device

21 (4.7%)

35 (6.5%)

14 (8.8%)

0 (0.0%)

49 (6.8%)

 Heart failure

16 (3.5%)

22 (4.1%)

3 (1.9%)

1 (4.5%)

26 (3.6%)

 Angina pectoris (stable/unstable)

25 (5.5%)

21 (3.9%)

3 (1.9%)

1 (4.5%)

25 (3.5%)

 Cardiomyopathy

7 (1.6%)

17 (3.2%)

4 (2.5%)

3 (13.6%)

24 (3.3%)

 MI

3 (0.7%)**

17 (3.2%)

4 (2.5%)

1 (4.5%)

22 (3.1%)

 PVD

18 (4.0%)

13 (2.4%)

5 (3.1%)

1 (4.5%)

19 (2.6%)

 SCAD

0 (0.0%)

3 (0.6%)

2 (1.3%)

0 (0.0%)

5 (0.7%)

 Other

10 (2.2%)

20 (3.7%)

6 (3.8%)

3 (13.6%)

29 (4.0%)

Cardiovascular risk factors

Hypertension

258 (57.0%)

314 (58.0%)

96 (60.4%)

13 (54.2%)

423 (58.4%)

 Family history

193 (42.7%)***

300 (55.7%)‡

70 (43.8%)‡

14 (58.3%)

384 (53.1%)†

 Dyslipidemia

241 (53.1%)

273 (50.7%)

77 (48.1%)

12 (50.0%)

362 (50.1%)

 Diabetes

116 (25.6%)

128 (23.7%)

46 (28.9%)

6 (25.0%)

180 (24.9%)

Comorbidities

 Sleep apnea

91 (20.0%)*

76 (14.0%)

19 (11.9%)

4 (16.7%)

99 (13.6%)

 Osteoarthritis

24 (5.3%)***

72 (13.3%)

26 (16.3%)

6 (25.0%)

104 (14.3%)

 Cancer

24 (5.3%)**

56 (10.3%)

15 (9.4%)

3 (12.5%)

74 (10.2%)

  1. N (%) or mean ± standard deviation shown
  2. CABG = coronary artery bypass graft; CAD = coronary artery disease; CR = cardiac rehabilitation; MI = myocardial infarction; N = sample size; PCI = percutaneous coronary intervention; PVD = peripheral vascular disease; SCAD = spontaneous coronary artery dissection; TIA = transient ischemic attack
  3. *Mann–Whitney U or chi-square test for difference between men and women in mixed-sex model: *P < .05, **P < .01, ***P < .001
  4. Kruskal–Wallis or chi-square test for difference between model among women: †P < .05; ††P < .01; †††P < .001
  5. Post-hoc test results, where above significant: ‡P < .05; ‡‡P < .01; ‡‡‡P < .001
  6. §Main referral event or procedure for each participant; in women, comparisons were only between supervised models due to low sample size in home-based